| T1 | T2 | Test value | P-value | Sig. | |
No. = 24 | No. = 28 | |||||
Response | CR | 22 (91.7%) | 24 (85.7%) | 0.449* | 0.503 | NS |
PR | 2 (8.3%) | 4 (14.3%) | ||||
Local recurrence | No | 24 (100.0%) | 22 (78.6%) | 5.814* | 0.016 | S |
Yes | 0 (0.0%) | 6 (21.4%) | ||||
Local control duration (months) | Median (IQR) | 14.5 (11 - 33) | 10.5 (6 - 20) | −2.023ǂ | 0.043 | S |
Range | 2 - 46 | 2.8 - 30 | ||||
Metastases | No | 24 (100.0%) | 28 (100.0%) | - | - | - |
Alive or dead at last FU | Alive | 20 (83.3%) | 26 (92.9%) | 1.148* | 0.284 | NS |
Dead | 4 (16.7%) | 2 (7.1%) | ||||
ORS months | Median (IQR) | 14.5 (11.5 - 33) | 12 (9.5 - 22) | −1.545ǂ | 0.122 | NS |
Range | 2 - 46 | 6 - 30 |